Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
When To Switch From Target Date Fund To Age Based Approach: Go. This intro covers when a switch makes sense and what signals to watch for in your plan.
25,368 articlesInvestors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
The SEC has moved to clarify which crypto assets fall under securities rules, saying that many assets—including staki...
The Treasury Department will assume management of about $180 billion in defaulted federal student loans, a decisive s...
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
SpaceX could become one of the biggest IPOs in history. This guide breaks down what to watch, what it means for your ...
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
A recent insider sale of 5,595 Hilton Grand Vacations shares has investors asking what it means for the stock. This g...
A pipeline-focused ETF is drawing retirees with its steady monthly payouts, delivering roughly 7.8% annual yield and ...
Kalshi unveils a new prediction market to price future GPU computing power, positioning compute oil as a key asset cl...
Investors watched AST SpaceMobile tumble on launch-delay fears after a Blue Origin test setback. This piece breaks do...
Starting with $1,000 doesn’t require luck or timing. This guide identifies the smartest Vanguard option for a straigh...